Ardena is a fully integrated CDMO with a core focus on bringing molecules to the clinics. Our full-service offering covers:

• Drug substance: Navigating your small-molecule API project through route scouting, development and manufacturing under accelerated timelines.

• Solid state research: Our High Throughput Screening methodology for salt, co-crystal, polymorph, and amorphous form screening speeds up the selection of a solid form qualifying for development.

• Drug product: Our expertise includes phase-appropriate development and manufacturing under cGMP conditions, and clinical packaging and logistics.

• Nanomedicines: As a a leading CDMO for nanomedicines, we provide scalable formulation, process, and analytical development as well as GMP manufacturing, enabling our customers to reach their clinical schedules in time.

• CMC Regulatory: With in-depth understanding of scientific writing, CMC documentation requirements, and regulatory processes, Ardena fast-tracks your product towards global approval.

• Bioanalysis: We offer solutions for all types of drug products and biomarkers, from small molecules to proteins including antibodies, ADCs, oligonucleotides and vaccines.